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Purpose: To develop sustained release matrix tablets of diltiazem hydrochloride (DTZ) using karaya 
gum (K) alone or in combination with locust bean gum (LB) and hydroxypropyl methylcellulose (H). 
Methods: Matrix tablets of DTZ were prepared at different ratios of drug:gum (1:1, 1:2, and 1:4) and of 
the gum blends (K, K/LB, K/H and K/LB/H) by direct compression. The matrix tablets were evaluated for 
hardness, friability, in vitro release and drug content. The formulations were also characterised by 
scanning electron microscopy (SEM), Fourier transform infra-red spectroscopy (FTIR) and differential 
scanning calorimetry (DSC). A commercial diltiazem hydrochloride product Dilzem SR, was used as a 
reference for comparison 
Results: Tablets with only K or K/H had the highest mean dissolution time (MDT), the least dissolution 
efficiency (DE, 12 %), and released drug by swelling, diffusion and erosion mechanisms. Karaya gum or 
combinations with locust bean gum sufficiently controlled drug release, while combinations of KH and 
KLBH exhibited high and low drug release efficiency, respectively. SEM images of the tablets before 
and after dissolution showed morphological changes on the tablet surface while FTIR and DSC studies 
indicate that there was no chemical interaction between the drug and the polymers. Three of the 
formulations compared well with the reference (p < 0.05) in terms of release characteristics. 
Conclusion: The results of the study demonstrate that karaya gum alone or in suitable combination with 
locust bean gum and hydroxypropyl methylcellulose is suitable for formulating sustained-release matrix 
tablets of diltiazem. 
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INTRODUCTION 
 
Hydrophilic matrix tablets have long been 
used as a drug delivery system. This is due 
to their simplicity, cost-effectiveness, reduced 
risk of systemic toxicity, and minimal chance 
of dose dumping. Matrix systems can be 
used to control the release of both water 
soluble and water insoluble drugs. On the 
surface, their drug release behavior appears 
simple, but the drug release pattern is a 
complex phenomenon. At the molecular level, 
it involves water penetration, polymer 
swelling, as well as drug dissolution, 
diffusion, swelling, and polymer erosion 
process [1-3].  
 
In recent years, researchers have become 
increasingly interested in the utilization of 
natural biopolymers due to their wide ranging 
advantages over synthetic polymers. 
Polysaccharide gums are the materials of 
choice because they are naturally abundant, 
biocompatible, biodegradable, and non-
immunogenic [4,5]. Gum karaya, sometimes 
known as Sterculia gum, is the dried exudate 
of the Sterculia urens tree and other species 
of Sterculia. It is a complex polysaccharide of 
high molecular weight which, on hydrolysis, 
yields galactose, rhamnose and galacturonic 
acid. It occurs as a partially acetylated 
derivative and is compatible with other plant 
hydrocolloids as well as proteins and 
carbohydrates. Few works on karaya gum 
have been reported [6-8].  
 
Locust bean gum (LB), also known as 
galactomannan, is obtained from the seed of 
the Locust bean plant, and composed of a 1, 
4-linked β-D-mannan backbone with 1, 6-
linked α-D-galactose side groups. It is a non-
ionic molecule consisting of 2,000 residues; 
the ratio of mannose to galactose in the 
molecule is 4:1. The physicochemical 
properties of galactomannan are strongly 
influenced by the galactose content and the 
distribution of the galactose units along the 
main chain. The structure contains long 
stretches of bare mannose backbone (up to 
80 D-mannose units long) which is 
responsible for synergistic interaction with 




HPMC (H) is a widely used semi-synthetic 
hydrophilic matrix polymer that has been 
employed in the design of sustained release 
formulations due to its rapid hydration, good 
compression and gelling characteristics as 
well as its ease of use, availability and very 
low toxicity [12].  
 
Diltiazem hydrochloride (DTZ) is a calcium 
channel blocker that is widely prescribed for 
the treatment of hypertension and angina. It 
is highly water soluble and almost completely 
absorbed. However, its bioavailability is 30 to 
40 % owing to first pass metabolism, and it 
has an elimination half-life of 3.5 h. 
Therefore, DTZ requires multiple daily drug 
dosage in order to maintain adequate plasma 
concentrations, and is thus a suitable model 
candidate for sustained drug delivery [13].  
 
The present study investigates karaya gum 
as a suitable, natural, low-cost hydrophilic 
matrix material for the formulation of 
sustained release tablets. Modulation of DTZ 
release from its matrix tablet using LB and H 








Diltiazem hydrochloride (DTZ), micro-
crystalline cellulose (MCC), and hydroxyl-
propyl methylcellulose (HPMC K4M) were 
obtained free of charge from Micro Lab Ltd, 
Bangalore, India. Locust bean gum (LB) and 
karaya gum (K) were purchased from Sigma 
Aldrich, Steinheim, Germany while 
magnesium stearate, hydrochloric acid, 
sodium hydroxide, and potassium phosphate 
monobasic were all obtained from Merck, 
Mumbai, India. All chemicals were either of 
pharmaceutical or analytical grade. The 
reference diltiazem hydrochloride tablet used 
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for the study was Dilzem SR (Torrent Pharma 
Ltd, India).  
 
Preparation of matrix tablets 
 
Matrix tablets of 100 mg diltiazem 
hydrochloride were prepared by direct 
compression method based on the 
composition shown in Table 1. The excipients 
(except magnesium stearate) and drug were 
first passed through 200 µ aperture sieve and 
then mixed in geometrical dilution for 10 min. 
Finally, the magnesium stearate was added 
and mixed for additional 2 min. The batch 
size of each formulation was 50 tablets. The 
tablets were compressed in a tablet machine 
(Rimek Mini Press I) using 12 mm flat-faced 
punches. 
 
Characterization of tablets 
 
The hardness, friability, weight variation, and 
content uniformity of the compressed matrix 
tablets were determined. Briefly, hardness 
was determined using a digital hardness 
tester (Inwika, Ahmedabad, India) while 
friability was assessed with a Roche friability 
testing apparatus. Weight variation and 
uniformity of drug content were assessed 
according to Indian Pharmacopoeia (IP) 
procedures [14]. Twenty tablets were 
weighed individually and average weight was 
determined. Not more than two tablets should 
show a deviation ± 5% of the mean weight. 
For content uniformity, 10 tablets were 
selected at random and the mean weight was 
calculated. The tablets were then powdered 
and a sample containing 100 mg of the drug 
was taken in a 100 ml volumetric flask. The 
volume was made up to mark with simulated 
gastric fluid (SGF, 0.1M HCl, pH 1.2). A 
portion of this solution (7.5ml) was 
transferred to 100 ml volumetric flask and 
diluted up to the mark with SGF; 3ml of this 
mixture  was diluted to 25 ml with SGF, 
filtered through 0.45 µm pore membrane and 
the absorbance measured spectrophoto-
metrically (model UVPC 1601, Shimadzu, 
Kyoto, Japan) at 237 nm.  
 
In vitro drug release studies
 
 
Drug release studies were performed using a 
USP type I apparatus (model TDT-08l, 
Electrolab, Mumbai, India) at 100 rpm and 
37
o
 C for the first 2 h in 900 mL SGF and 
then at pH 7.4 in 900 mL of phosphate buffer 
for another 10 h. Two millilitres of the 
dissolution samples were taken at different 
time intervals and replaced with an equal 
volume of drug-free dissolution fluid to 
maintain sink conditions. The samples were 
suitably diluted with blank dissolution fluid 
and analyzed for DTZ 
spectrophotometrically.at 237 nm [15].  
 
Scanning electron microscopy (SEM) 
 
The surface morphology of the matrix tablets 
was analyzed with a scanning electron 
microscope (JEOL-JSM-840A, Japan).  
 
Water uptake and erosion studies
 
 
Erosion and water uptake of the tableted 
formulations were determined under 
conditions identical to those described for 
dissolution testing using SGF as the medium. 
Three tablets were used at each time interval. 
At the predetermined times, the tablets were 
lightly patted with tissue paper to remove 
excess surface water. The swollen weight of 
the tablets was determined (Ts), The tablets 
were then dried in a vacuum oven at 40 °C 
for 48 h and their dry weight (Tf) was 
determined. The study was carried out in 
triplicate. Swelling (%) and erosion (%) was 
calculated using Eqs 1 and 2, respectively 
[19]. 
 
Swelling (%) = (Ts – T)/T x 100   ……...  (1) 
 
where Ts is the weight of the swollen tablet 
and T is the initial weight of the tablet, i.e., 
prior to the test. 
 
Erosion (%) = (T – Tf)/Tf x 100   ………  (2) 
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where T is the initial weight of the tablet and 





In order to evaluate the compatibility of the 
drug and the polymers used, FT-IR studies 
were carried out with a Shimadzu FTIR 





Thermal analysis was carried out with a 
differential scanning calorimeter (DSC, 
Perkin-Elmer, Pyris-1). Scanning was 
performed at a temperature ranging from 40 
to 280 
0
C at a heating rate of 10 
0
C/min under 
an atmosphere of nitrogen. The sample 
weight was 2 - 4 mg and it was sealed in a 
perforated aluminium pan.       
 
Kinetic analysis of dissolution data
 
 
To study the mechanism of drug release from 
the matrix tablets, the release data were fitted 
to zero-order, first-order, and Higuchi 
equations. The dissolution data were also 
fitted to the well-known Korsemeyer 
exponential equation, which is often used to 
describe drug release behavior from 
polymeric systems.  
                                                           
( ) nLogtLogkMMLog ft += …….  (3)  
 
The diffusional exponent “n”, which is 
indicative of the mechanism of drug release, 
was obtained by plotting the log value of 
percent drug released against log time for 
each batch according to Eq 3. A value of n = 
0.45 indicates Fickian (case I) release; > 0.45 
but < 0.89 is non-Fickian (anomalous) 
release; and > 0.89 indicates super case II 
type of release. Case II generally refers to the 
erosion of the polymeric chain, and 
anomalous transport (non-Fickian) refers to a 
combination of both diffusion and erosion 
controlled-drug release. Model-independent 
approaches, i.e., dissolution efficiency (DE) 
which is defined as the area under the 
dissolution curve up to a certain time t, 
expressed as a percentage of the area of the 
rectangle described by 100 % dissolution in 
the same time range, and mean dissolution 
time (MDT), were used to translate the profile 
differences into a single value as shown in 














MDT is a measure of the dissolution rate: the 




















where i is the dissolution sample number, n is 
the number of dissolution sample time, tmid is 
the time at the midpoint between i and i-1, 
and ∆M is the amount of drug dissolved 
between i and i-l. The similarities between 
two dissolution profiles were assessed by a 
pair-wise model-independent procedure, 




































where n is the number of pull points, Rt is the 
reference profile at time point t, and Tt is the 
test profile at the same time point; the value 
of f2 should be between 50 and 100. An f2 
value of 100 suggests that the test and 
reference profiles are identical and, as the 
value becomes smaller, the dissimilarity 




Comparison among the developed 
formulations and the reference formulation 
(Dilzem SR) were made by Student t-test at 
…………….....  (4) 
 
………......  (5) 
….(6) 
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95 % level of confidence using Microsoft 




Characterization of tablets 
 
The compositions of the matrix tablets and 
the results of the physical characterization of 
tablets are summarized in Table 1. Tablet 
friability was less than 1 % while hardness 
ranged from 4 - 6 kg/cm
2
. Good uniformity in 
drug content was found among the various 
formulation batches was drug content was 
more than 96 % in all cases with less than 1 
% standard deviation. Thus, all the tablet 




Table 1: Composition and physical characteristics of diltiazem hydrochloride  






























































K(1:1)         F1 
K(1:2)         F2 
K(1:4)         F3 
KLB(1:1)    F4 
KLB(1:2)    F5 
KLB(1:4)    F6 
KH(1:1)      F7 
KH(1:2)      F8 














































Note: Magnesium.stearate (10 mg/tablet) was added as glidant-lubricant to all  
the tablet formulations   
 
 
  Table 2: Kinetic parameters of the dissolution data 
 
Formulation n Peppas Higuchi MDT(h) ± 
SD 
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In vitro drug release and kinetic analysis
 
 
The release profiles of the tablets made with 
K and KLB blend are presented in Figure 1A.  
The initial drug released in the 1st hour 
ranged from 13 – 26 % for K formulations but 
at the end of 12 h, the value rose to between 
50 and 81 %, indicating that the tablets 
extended release for more than 12 h. For 
matrix tablets formulated with KLB polymer 
blend in 1:1 (drug: polymer) ratio, the initial 
release in the 1st hour ranged from 18 – 83 
%. At the end of 12 h, the figure was between 
75 and 98 %. The release profiles of the 
tablets made with polymer blends KH and  
KLBH are presented in Figure 1B. The tablets 
containing KH blend in 1:1 ratio as the matrix 
(i.e., formulations F7, F8 and F9) showed 15 
– 24 % release in the first hour and a 
cumulative release of 48 – 71 % at the end of 
12 h. On the other hand, the tablets 
containing the polymer blend K:LB:H 
(1.0:0.5:0.5) as the matrix showed a 
cumulative release of 53 – 92 % at the end of 













Figure 1:  Dissolution profile of formulations. 
(Note: For A,  = F1;  = F2;   = F3;  = F4;  
= F5;  = F6, while for B,  = F7;  = F8;  = 
F9;  = F10;  = F11;  = F12; + = DIL) 
 
The results of kinetic analysis of the 
dissolution data, mean dissolution time 
(MDT) and DE12 of all the formulations are 
shown in Table 2. MDT values ranged from 
0.87 - 4.54 h while dissolution efficiency 
(DE12) at the end of 12 h was 34 – 91 %. The 
drug release data of the tablet formulations 
did not fit satisfactorily to zero-order, first-
order, and Higuchi models but  showed good 
fit to the Korsmeyer model (r
2
 = 0.9652 to 
0.9976) and to some degree the Higuchi 
model (r
2
 = 0.879 to 0.9898). The value of the 
release exponent, “n”, for the various 
matrices ranged from 0.4700 to 0.6889. F5 
had MDT and dissolution efficiency (DE12 %) 
similar to those of the standard product, 
Dilzem SR. The similarity factor (f2) was 
77.86, suggesting that their dissolution 
profiles were very similar.  
 
Scanning electron microscopy (SEM) 
 
Figure 2 displays the scanning electron 
micrographs showing the surface morphology 
of formulation F5. The SEM photos show that 





Figure 2: SEM photographs of formulation F5 
before (A) and after dissolution (B) 
 
Water uptake and erosion 
 
Figure 3 shows the water uptake and erosion 
profiles of optimized formulation F5 and 
reference. Tablet swelling and erosion at the 
end of 12 h was 172, and 250 %.  33.4 and 
33 %, respectively. 
Figure 3: Swelling and eroding behaviour of 
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FT-IR spectroscopy 
 
The FTIR spectra of both the pure drug and 
one of the matrix formulations (not presented 
here) showed characteristic peaks at 3433.13 
cm
-1
 (aliphatic C-H stretching), 2931.90 cm
-1
 
(O-CH3, C-H stretching), 2387.93 cm
-1
 
(amine HCl, N-H stretching), 1741.78 cm
-1
 
(acetate C=O stretch), 1678.13 cm
-1
 (lactam 
C=O stretch), 831.33 cm
-1
 (O-substituted 
aromatic C-H out of plane-deformation), 
773.48 cm
-1
 (p-substituted aromatic C-H out 
of plane-deformation) thus indicating that 





The DSC thermograms of one of the 
formulations and pure DTZ showed 
endothermic peaks for the pure DTZ and the 





Of all the formulations, only F1, F5, and F10 
did not significantly differ in terms of drug 
release (p < 0.05) from the commercial DTZ 




The matrix tablets exhibited satisfactory 
mechanical characteristics based on the 
friability and hardness data presented. 
Content uniformity was also good. The slower 
and more sustained drug release from khaya 
(K) formulation (F3), compared to the control, 
can be attributed to high gum hydration with 
concurrent swelling, followed by gradual 
erosion. This appears to be confirmed by 
higher MDT and lower dissolution efficiency. 
In matrix tablets containing a mixture of 
polymers K and LB in a ratio of 1:1, drug 
release increased as the amount of polymer 
blend decreased. Formulations F5 and F6 
showed extended drug release over a period 
that exceeded 12 h. Formulation F4 (K:LB in 
1:1 ratio) showed the most rapid release (83 
% in 1 h), the least MDT (0.8 h) and highest 
dissolution efficiency (99 % after 12 h) thus 
indicating that this polymer mixture was 
unable to sustain drug release. This may be 
explained as follows. Studies have shown 
that LB gum is less soluble and viscous than 
khaya gum as it has fewer galactose branch 
points. Thus, the hydrated matrix lacked gel 
integrity, resulting in higher erosion. An 
earlier stidy indicates that LB displayed a 
high erosion rate and low swelling than K 
[20].  The matrrices containing a mixture of K 
and H in 1:1 ratio (F7, F8 and F9) showed 
more pronounced sustained release than 
those containing K alone and K/LB blend 
when compared to HPMC. This is probably 
due to the fact that K and LB gums are more 
hydrophilic, and, therefore showed greater 
water uptake and erosion than H (i.e., 
HPMC). Thus, the HPMC in the blend 
increased the integrity and resistance of the 
matrix to erosion. Furthermore, the high 
viscosity of the gel formed resulted in longer 
diffusional path length, thus retarding drug 
diffusion and resulting in high MDT values. 
Therefore, there is synergism between khaya 
gum and HPMC to effect sustained release. 
This is in agreement with earlier results 
obtained for karaya gum [15] and LB matrices 
[11]. Formulation of triple mixtures is capable 
of sustaining drug release considering their 
MDT. However, the 2 polymer blends or K 
alone, showed release profiles similar to the 
reference commercial formulation, indicating 
there was no synergism between the 3 
polymers [19]. 
 
The release data showed high linearity with 
the Korsmeyer model. The values of release 
exponent “n” were characteristic of 
anomalous kinetics (non-Fickian) and 
indicate a combined effect of diffusion and 
erosion mechanisms for controlled drug 
release. For all the formulations, there was 
contribution from polymer relaxation to the 
dissolution process as “n” value approaches 
anomalous transport. Relaxational contri-
bution was higher for the formulations with 
higher “n” values [10]. 
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The SEM photomicrograph of the tablets 8 h 
after hydration commenced showed a highly 
porous tablet surface which probably also 
reflects a porous tablet matrix structure. This 
would facilitate diffusion of drug from the 
tablet core to the surface. Since the gel layer 
undergoes surface erosion, it is possible that 
the inner porous network is exposed after the 
dissolution of the outer layer of the matrix. 
The formation of both pores and gel structure 
on the tablet surface indicates involvement of 
both erosion and diffusion mechanisms for 
sustained drug release [16]. 
 
Thus, the matrices underwent both swelling 
and erosion at the same time immediately 
after placement in the dissolution medium, 
and this continued over the 12 h period of the 
study. Formulation F5 and the reference DTZ 
had overlapping erosion profiles throughout 
the study period but their swelling behaviour 
were similar only up to the 6th hour. 
However, the swelling profile of F5 was 
similar to those reported earlier for K, LB and 
xanthan matrices containing a different water 
soluble drug [20]. 
The FTIR spectra of the pure drug and the 
test formulation showed characteristic peaks 
for both pure DTZ and DTZ in the test 
formulation without any significant shift in 
their positions. Also, the DSC endothermic 
peaks for the pure drug and the drug in the 
test formulation showed only a negligible shift 
in their positions with some peak broadening 
in the latter. Thus, the likelihood of any 
chemical interaction between the drug and 
the polymers used can be ruled out. 
 
CONCLUSION   
 
Previous studies have shown locust bean 
gum alone cannot efficiently control drug 
release. This study demonstrates that its 
combination with khaya gum is synergistic in 
controlling diltiazem release. Combination of 
khaya gum with HPMC led to even greater 
sustained than khaya gum or its combination 
with locust bean LB gum. Based on a derived 
dissolution parameter, f2, the formulation 
containing khaya and locust bean gums in a 
ratio of 1:2 (i.e., F5) was closest to the 
commercial diltiazem tablet used as 
standard. Thus, a suitable combination of the 
two natural gums (khaya amd locust bean 
gums/ may be successfully employed for 
formulating sustained-release matrix tablets 
of diltiazem.  
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